Interactive Transition Support for Adolescents Living with HIV using Social Media (InTSHA): Research Protocol (Preprint)
BACKGROUND Adolescents living with perinatally-acquired HIV often have poor retention in care and viral suppression during the transition from pediatric to adult based care. OBJECTIVE To evaluate a mobile phone-based intervention, InTSHA: Interactive Transition Support for Adolescents Living with HIV using Social Media, among adolescents living with perinatally-acquired HIV as they transition from pediatric to adult care in South Africa. METHODS InTSHA uses encrypted, closed group chats delivered via WhatsApp to develop peer support and improve communication between adolescents, their caregivers, and healthcare providers. The intervention is based on formative work with adolescents, caregivers, and healthcare providers and builds on several existing adolescent support programs as well as the Socioecological Model for Adolescent and Young Adult Readiness to Transition (SMART). The final InTSHA intervention involves ten modules conducted weekly through moderated WhatsApp group chats with adolescents and separately with their caregivers. We will randomize 80 South African adolescents living with perinatally-acquired HIV who are aware of their HIV status and aged between 15 to 19 years to receive either the intervention (n=40) or standard of care (n=40). RESULTS We will measure acceptability of the intervention as primary outcome and evaluate feasibility and preliminary effectiveness for retention in care and viral suppression after completion of the intervention and at least six months after randomization. In addition, we will measure secondary outcomes evaluating the impact of the InTSHA intervention on peer support, self-esteem, depression, stigma, sexual education, connection to healthcare providers and transition readiness. CONCLUSIONS If successful, the intervention will be evaluated in a fully powered randomized controlled trial with a larger number of adolescents from urban and rural populations to further evaluate the generalizability of InTSHA. CLINICALTRIAL ClinicalTrials.gov Identifier: NCT03624413